Related Experiment Video
Updated: Feb 22, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Acromegaly with hypophosphataemia: McCune-Albright syndrome
Rimesh Pal1, Pinaki Dutta1, Kanchan Kumar Mukherjee2
1Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Abstract:
A 38-year-old man presented with excessive height gain and progressive enlargement of the extremities since childhood. This was compounded by lower limb deformities over the past 5 years. On examination, his height was 196 cm, he had macroglossia, acral enlargement, seborrhoea, hyperhidrosis-suggesting acrogigantism. He had facial asymmetry, wind-swept deformity of lower limbs and a café-au-lait macule over his trunk. Investigations revealed normal-sized pituitary gland with dysplastic cranial bones. Isotope bone scintigraphy was suggestive of polyostotic fibrous dysplasia. A diagnosis of McCune-Albright syndrome was made and trans-sphenoidal hypophysectomy was undertaken. He had persistent hypophosphataemia. Tubular reabsorption of phosphate adjusted for glomerular filtration rate was low and serum FGF-23 level was high. Ga-DOTATATE scintigraphy showed somatostatin-receptor expression in all the dysplastic lesions. FGF-23 produced by the bony lesions could counteract the phosphate-retaining effect of GH excess resulting in hypophosphataemia, which further worsened following hypophysectomy.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Related Concept Videos
Abnormal Proliferation
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Chronic Kidney Disease II: Clinical Manifestations
Inborn Errors of Metabolism
Cardiomyopathy III: Hypertrophic Cardiomyopathy